Johnson & Johnson voluntarily recalled several of its aerosol sunscreen products recently after discovering trace amounts of a potential carcinogen in samples. While the levels detected were low, the company suggests consumers should stop using the products and throw them…
Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.
To spotlight the impact nurses have on leading innovation and advancing new models of care the American Association of Colleges of Nursing (AACN) is creating new teaching tools designed to inspire the next generation of nurses to serve with courage, ingenuity, and compassion.
Everyone who gets vaccinated for COVID-19 in the U.S. receives a vaccine card. Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York, offers insight into why vaccine cards are important and why you…
A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses. Tinglong Dai is an…
FAU’s Joanna Drowos, D.O., M.P.H., M.B.A., provides answers to some of the most frequently asked questions regarding COVID-19 vaccines.
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site and their challenges and successes. The Rutgers J&J trial site was the second-largest clinical trial for the company.
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
Details on the groundbreaking partnership between ADHA, Johnhon & Johnson and Walgreens taking place during October